Losing weight — and keeping it off — linked to cardiometabolic benefits
People who lose weight and keep it off can stabilize or even improve their cardiometabolic risk factors compared to people who regain weight, finds a new study.
Read morePeople who lose weight and keep it off can stabilize or even improve their cardiometabolic risk factors compared to people who regain weight, finds a new study.
Read moreA recent analysis reveals that treatment of male breast cancer has evolved over the years. In addition, certain patient-, tumor-, and treatment-related factors are linked with better survival.
Read moreResearchers have successfully grown human, testosterone-producing cells in the lab, paving the way to someday treat low testosterone with personalized replacement cells.
Read moreResults from the first long-term cohort study of more than 36,000 Japanese men over decades suggest an association between eating mushrooms and a lower risk of prostate cancer.
Read moreA research study has identified a novel prostate cancer gene fusion involving the KLK4 protein coding gene and KLKP1 pseudogene. This unique biomarker can be detected in the urine samples of patients with prostate cancer, offering a non-invasive means of detection.
Read moreFor the first time, prostate cancer has been treated based on the genetic makeup of the cancer, resulting in delayed disease progression, delayed time to pain progression, and potentially extending lives in patients with advanced, metastatic prostate cancer, reports a large phase 3 trial. This marks a significant advance for prostate cancer treatment, which has lagged behind other common cancers with regard to precision therapy, now the standard of care in breast, ovarian and lung cancers.
Read moreMen with prostate cancer can be spared radiotherapy after surgery, according to new results. The study answers a longstanding question about whether the benefits of radiotherapy after surgery outweigh the side-effects.
Read moreA randomized clinical trial of targeted, high-dose radiation for men with oligometastatic prostate cancer has shown the treatment to be an effective and safe option for patients who wish to delay hormone-suppression therapy. The phase II trial found that radiation therapy can generate an immune system response not previously believed possible in this type of cancer.
Read moreMen who became fathers through assisted reproduction techniques seem to be at higher risk for prostate cancer and early onset prostate cancer compared with men achieving fatherhood naturally.
Read moreThere is growing evidence that Parkinson's disease (PD) affects women and men differently. In this insightful review, scientists present the most recent knowledge about these sex-related differences and highlight the significance of estrogens, which play an important role in the sex differences in PD.
Read more